Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Cyclic innovation to drive the Hospital Acquired Infection Control Market

The Spirulina Extract Market’S Growth Is To Be Defined By Innovation Continuously

The global Hospital Acquired Infection Control Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely feedback. This trend is bound to take the overall industry at a greater stride in the upcoming period.

According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period.

This report tracks the performance of the global hospital acquired infections control market for a period of eight years between 2017 and 2025. A growing prevalence of hospital acquired infections across the globe, rising awareness and demand for new and improved hospital acquired infections treatment modalities, and a rapidly expanding healthcare infrastructure are some of the driving factors of the global hospital acquired infections control market.

Planning Forward? Access Sample Of Hospital Acquired Infection Control Market Report! https://www.persistencemarketresearch.co/samples/2814

Company Profile

  • Olympus Corporation
  • Medivators Inc. (Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG (Metall Zug)
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc

Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Hospital Acquired Infection Control Market? https://www.persistencemarketresearch.co/methodology/2814

Global Hospital Acquired Infections Control Market: Restraints

  • Reported adverse events from failure of endoscope reprocessing to hinder market growth
  • Excise duty imposed on medical device manufacturers would reduce profit margins
  • High cost of technology hampering revenue growth of the hospital acquired infections control market
  • Inadequate reimbursement policies to restrain market growth
  • Delayed reprocessing and lack of clarity of instruction is a challenge
  • Stringent rules and regulations to hamper the growth rate of the global market
  • Low awareness of endoscope reprocessing in developing countries is another restraint
  • Lack of proper healthcare infrastructure in emerging markets is also restricting revenue growth of the global market

Global Hospital Acquired Infections Control Market: Forecast by Product Type

On the basis of product type, the global hospital acquired infections control market is segmented into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and disinfection equipment.

In terms of revenue, disinfection equipment was the dominant product type in the global hospital acquired infections control market in 2016. In terms of growth, low temperature sterilization equipment is expected to be the fastest growing segment, registering a CAGR of 5.3% over the forecast period.

Planning To Introduce An Offbeat Product/Technology In The Hospital Acquired Infection Control Market? Go To “Purchase Now” To Have Our Hospital Acquired Infection Control Market Report! https://www.persistencemarketresearch.com/checkout/2814

Global Hospital Acquired Infections Control Market: Forecast by End User

On the basis of end user, the global market for hospital acquired infections control is segmented into hospitals, ambulatory surgery centers, medical institutions, diagnostic laboratories and clinics.

Hospitals dominated the global hospital acquired infections control market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Hospitals are expected to be the most lucrative among all end users, with a market attractiveness index of 1.6.

Global Hospital Acquired Infections Control Market: Forecast by Region

Five regional markets namely North America, Latin America, Europe, APAC and MEA are studied in this report. North America dominated the global hospital acquired infections control market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

North America is anticipated to be the most attractive regional market with an attractiveness index of 1.7 during the forecast period. Acceptance of newly developed therapeutic procedures in bacterial infections are expected to continue to provide future growth opportunities in the North America hospital acquired infections control market.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

 

Continue Reading